EA1183
FDG PET to Assess Therapeutic Response in Patients with Bone-dominant Metastatic Breast Cancer, FEATURE
Trial overview
| Disease | Breast cancer treatment and diagnosis |
| Topic | EA1183 |
| Description | Primary Objective Evaluate the performance of FDG-PET/CT response criteria (modified PERCIST complete, partial and stable metabolic disease versus progressive metabolic disease) as a binary predictor of PFS in patients with BD MBC treated with systemic therapy |
| Physicians | Dr. Mohammad JahanzebMD, FACP, FASCO Medical Oncologist Works at 3 centers.Dr. Edgardo SantosMD Medical Oncologist Works at 3 centers. |